Tech Company Financing Transactions

Novome Biotechnologies Funding Round

Novome Biotechnologies secured a $33 million Series A funding round on 1/8/2020. Investors included Data Collective, 5AM Ventures and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

279 E Grand Ave. 420
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.novomebio.com

Email Address

[email protected]

Overview

Novome Biotechnologies is engineering bacteria from the human gut to treat diseases. Based on pioneering technology developed at Stanford University, we bring together experts in the fields of synthetic biology and the microbiome to build novel cell-based therapies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Blake Wise

        

Chief Scientific Officer

William DeLoache

        

Co-Founder

Zachary Russ

        

Co-Founder

Elizabeth Shepherd

        

Controller

Shu Kurosaki

        

VP - Bus. Development

Lane Weaver

        

VP - R & D

Weston Whitaker

        

Browse more venture capital transactions:

Prev: 1/7/2020: Repisodic venture capital transaction
Next: 1/8/2020: Ripple Science venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary